Drugs / Cancer vaccine
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01702792 | Jan 2014 → May 2015 | glioblastoma | Dartmouth-Hitchcock Medical Center | Terminated | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01081223 | Apr 2010 → Mar 2011 | glioblastoma | TVAX Biomedical | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cancer vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01081223 ↗ |
| Known as | Tumor Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01702792 ↗ |
| Modality | Vaccine | “Tumor tissue is used for cancer vaccine.” NCT01081223 ↗ |